For general inquiries, call 1 877-564-0008 or [email protected]. Fax PoNS device prescriptions to 1 (215) 754-4903.

Neurophysiology of Gait

Gait control requires activation of nearly the entire nervous system and musculoskeletal system.

This function is regulated by automatic and voluntary processes.

The cerebellum regulates the cognitive and automatic processes of posture-gait control by acting on the cerebral cortex and the brainstem, respectively.

Voluntary movements result from intentional motor signals traveling from the cerebral cortex to the brainstem and spinal cord.

This voluntary process is always linked to automatic mechanisms of postural control including balance adjustment and muscle tone regulation controlled by the limbic system, the brainstem, and the spinal cord.

Gait Deficit in MS

Walking impairment is a hallmark feature of MS and a common method of monitoring the progress of disease and neurological disability in MS; gait deficits are common in people with MS, irrespective of disease course, and are one of the main causes of disability.

In a study assessing the disruptive effects of individual MS-associated problems on the lives of people with MS who experience these problems at least twice a week, individuals report walking impairment/motor disability as one of the most impactful consequences of their disease.

Patients most frequently rate walking as the bodily function of greatest importance, valued more highly than vision, thinking and memory, and speech, regardless of level of disability or disease duration.

REFERENCES:
Larocca NG. Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient. 2011;4(3):189‒201. Motl RW, Learmonth YC. Neurological disability and its association with walking impairment in multiple sclerosis: brief review. Neurodegener Dis Manag. 2014;4(6):491‒500.
Cameron MH, Nilsagard Y. Balance, gait, and falls in multiple sclerosis. Handb Clin Neurol. 2018;159:237‒250.
Myhr KM, Riise T, Vedeler C, et al. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler. 2001;7(1):59‒65.
Takakusaki K. Neurophysiology of gait: from the spinal cord to the frontal lobe. Mov Disord. 2013;(11):1483–1491.
Takakusaki K. Functional neuroanatomy for posture and gait control. J Mov Disord. 2017;10(1):1–17.
Barthélemy D, Grey MJ, Nielsen JB, Bouyer L. Involvement of the corticospinal tract in the control of human gait. Prog Brain Res. 2011;192:181–197.

By submitting this form, you agree to receive future updates and communication regarding the PoNS® device and other Helius products, services, programs or topics of interest. Your consent is not required as a condition of receiving any goods or services from Helius. You may choose unsubscribe and choose not to receive further information from Helius by emailing [email protected]

IMPORTANT SAFETY INFORMATION

No serious adverse events related to the PoNS device were reported in the MS RCTs or in use in clinical rehabilitation settings to treat balance and gait disorders.

Some individuals have reported headaches, fatigue, and excess salivation. Excess salivation during training sessions often occurs but generally improves as patients get used to wearing the mouthpiece.

Indication
The PoNS® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.

Contraindications
The PoNS® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).

Electrical stimulation should not be used:

  • If there is an active or suspected malignant tumor
  • In areas of recent bleeding or open wounds
  • In areas that lack normal sensation

The PoNS® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS® if you are sensitive to nickel, gold or copper.

Use with caution
Electrical stimulation should only be used after seeking professional medical advice, and with caution in patients with any of the following:

  • Implanted electronic devices, including:
    • Cardiac pacemakers
    • Cardioverter defibrillators
    • Deep Brain Stimulators
    • Vagal Nerve Stimulators
    • Sacral nerve stimulators
    • Cochlear Implants
  • Metal in the mouth (e.g. piercings, braces, retainers, or other orthodontic appliance)
  • Seizure disorders
  • Epilepsy

Ready to get started with PoNS?

Patients who are seeking more information on how to get PoNS can email us at [email protected], or fill out our contact form: